Literature DB >> 33148492

Recent research progress of Uncaria spp. based on alkaloids: phytochemistry, pharmacology and structural chemistry.

Nan Qin1, Xin Lu2, Yijun Liu2, Yuting Qiao2, Wei Qu1, Feng Feng3, Haopeng Sun4.   

Abstract

Medicinal plants are well-known in affording clinically useful agents, with rich medicinal values by combining with disease targets through various mechanisms. Plant secondary metabolites as lead compounds lay the foundation for the discovery and development of new drugs in disease treatment. Genus Uncaria from Rubiaceae family is a significant plant source of active alkaloids, with anti-hypertensive, sedative, anti-Alzheimer's disease, anti-drug addiction and anti-inflammatory effects. This review summarizes and discuss the research progress of Uncaria based on alkaloids in the past 15 years, mainly in the past 5 years, including biosynthesis, phytochemistry, pharmacology and structural chemistry. Among, focusing on representative compounds rhynchophylline and isorhynchophylline, the pharmacological activities surrounding the central nervous system and cardiovascular system are described in detail. On the basis of case studies, this article provides a brief overview of the synthesis and analogues of representative compounds types. In summary, this review provides an early basis for further searching for new targets and activities, discussing the mechanisms of pharmacological activity and studying the structure-activity relationships of active molecules.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Alkaloids; Genus Uncaria; Isomerization; Pharmacology; Phytochemistry; Synthesis

Mesh:

Substances:

Year:  2020        PMID: 33148492     DOI: 10.1016/j.ejmech.2020.112960

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  7 in total

1.  Transcriptome revealing the dual regulatory mechanism of ethylene on the rhynchophylline and isorhynchophylline in Uncaria rhynchophylla.

Authors:  Xue Li; Xiao-Hong Wang; Wei Qiang; Hao-Jie Zheng; Li-Yang ShangGuan; Ming-Sheng Zhang
Journal:  J Plant Res       Date:  2022-04-05       Impact factor: 2.629

2.  Dissecting the Regulation of Arachidonic Acid Metabolites by Uncaria rhynchophylla (Miq). Miq. in Spontaneously Hypertensive Rats and the Predictive Target sEH in the Anti-Hypertensive Effect Based on Metabolomics and Molecular Docking.

Authors:  Lei Gao; Xinqin Kong; Wenyong Wu; Zijin Feng; Haijuan Zhi; Zijia Zhang; Huali Long; Min Lei; Jinjun Hou; Wanying Wu; De-An Guo
Journal:  Front Pharmacol       Date:  2022-05-30       Impact factor: 5.988

3.  The complete chloroplast genome of Uncaria macrophylla Wall. (Rubiaceae) and its phylogenetic analysis.

Authors:  Ni Zhang; Junrong Song; Hanfei Liu; Fei Li; Weidong Pan
Journal:  Mitochondrial DNA B Resour       Date:  2022-05-13       Impact factor: 0.610

4.  Tengdan Capsule Prevents Hypertensive Kidney Damage in SHR by Inhibiting Periostin-Mediated Renal Fibrosis.

Authors:  Xiaoli Du; Qianqian Tao; Hongxia Du; Zhenbang Zhao; Yu Dong; Shuang He; Rui Shao; Yule Wang; Wenrun Han; Xintong Wang; Yan Zhu
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

Review 5.  Traditional Herbal Medicine Discovery for the Treatment and Prevention of Pulmonary Arterial Hypertension.

Authors:  Zhifeng Xue; Yixuan Li; Mengen Zhou; Zhidong Liu; Guanwei Fan; Xiaoying Wang; Yan Zhu; Jian Yang
Journal:  Front Pharmacol       Date:  2021-11-09       Impact factor: 5.810

Review 6.  Synergistic Effects of Natural Product Combinations in Protecting the Endothelium Against Cardiovascular Risk Factors.

Authors:  Muhammad Yousaf; Valentina Razmovski-Naumovski; Muhammad Zubair; Dennis Chang; Xian Zhou
Journal:  J Evid Based Integr Med       Date:  2022 Jan-Dec

Review 7.  Current Research of Phytochemical, Medicinal and Non-Medicinal Uses of Uncaria gambir Roxb.: A Review.

Authors:  Indah Putri Munggari; Dikdik Kurnia; Yusi Deawati; Euis Julaeha
Journal:  Molecules       Date:  2022-10-03       Impact factor: 4.927

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.